Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 40 contracts
Sources: Registration Rights Agreement (Lightwave Logic, Inc.), Registration Rights Agreement (Workhorse Group Inc.), Registration Rights Agreement (Cognition Therapeutics Inc)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 30 contracts
Sources: Registration Rights Agreement (Grace Therapeutics, Inc.), Registration Rights Agreement (Crescent Biopharma, Inc.), Registration Rights Agreement (Brazil Potash Corp.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 25 contracts
Sources: Registration Rights Agreement (Telomir Pharmaceuticals, Inc.), Registration Rights Agreement (Beyond Air, Inc.), Registration Rights Agreement (Eloxx Pharmaceuticals, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 22 contracts
Sources: Registration Rights Agreement (WhiteHawk Minerals Corp.), Registration Rights Agreement (Lisata Therapeutics, Inc.), Securities Purchase Agreement (Skye Bioscience, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding the Investor.
Appears in 13 contracts
Sources: Registration Rights Agreement (Fulcrum Therapeutics, Inc.), Registration Rights Agreement (Synlogic, Inc.), Registration Rights Agreement (NextCure, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 10 contracts
Sources: Registration Rights Agreement (Acumen Pharmaceuticals, Inc.), Registration Rights Agreement (GRAIL, Inc.), Registration Rights Agreement (Oruka Therapeutics, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional informationinformation regarding the Investors.
Appears in 10 contracts
Sources: Registration Rights Agreement (Atrium Therapeutics, Inc.), Registration Rights Agreement (Edesa Biotech, Inc.), Registration Rights Agreement (Q32 Bio Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time Investors when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 9 contracts
Sources: Registration Rights Agreement (Pineapple Financial Inc.), Registration Rights Agreement (Portage Biotech Inc.), Registration Rights Agreement (MEI Pharma, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 7 contracts
Sources: Registration Rights Agreement (Enveric Biosciences, Inc.), Registration Rights Agreement (Enveric Biosciences, Inc.), Registration Rights Agreement (Advent Technologies Holdings, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information, in each case applicable to the Registrable Securities.
Appears in 6 contracts
Sources: Registration Rights Agreement (X4 Pharmaceuticals, Inc), Registration Rights Agreement (Humacyte, Inc.), Registration Rights Agreement (Meta Materials Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 6 contracts
Sources: Registration Rights Agreement (Karyopharm Therapeutics Inc.), Registration Rights Agreement (Karyopharm Therapeutics Inc.), Registration Rights Agreement (Karyopharm Therapeutics Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time Investors when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 5 contracts
Sources: Registration Rights Agreement (Vor Biopharma Inc.), Registration Rights Agreement (Vor Biopharma Inc.), Registration Rights Agreement (Vor Biopharma Inc.)
Notifications. The Company will notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 5 contracts
Sources: Registration Rights Agreement (Chemomab Therapeutics Ltd.), Registration Rights Agreement (Healthstream Inc), Registration Rights Agreement (Pyxis Oncology, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 3 contracts
Sources: Registration Rights Agreement (First Tracks Biotherapeutics, Inc.), Securities Purchase Agreement (First Tracks Biotherapeutics, Inc.), Registration Rights Agreement (Quoin Pharmaceuticals, Ltd.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf applicable Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the applicable Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 3 contracts
Sources: Registration Rights Agreement (In8bio, Inc.), Registration Rights Agreement (Equillium, Inc.), Registration Rights Agreement (Equillium, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 3 contracts
Sources: Registration Rights Agreement (Kiora Pharmaceuticals Inc), Registration Rights Agreement (Alto Neuroscience, Inc.), Registration Rights Agreement (Alto Neuroscience, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Resale Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding the Investors.
Appears in 3 contracts
Sources: Registration Rights Agreement (Obsidian Therapeutics, Inc.), Registration Rights Agreement (Gazelle Parent, Inc.), Registration Rights Agreement (Galera Therapeutics, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Shelf Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (electroCore, Inc.), Registration Rights Agreement (Transenterix, Inc.)
Notifications. The Company will notify the Investor Buyer promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Alterola Biotech Inc.), Registration Rights Agreement (Bloomios, Inc.)
Notifications. The Company will notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 2 contracts
Sources: Merger Agreement (Adial Pharmaceuticals, Inc.), Registration Rights Agreement (Adial Pharmaceuticals, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding the Investors.
Appears in 2 contracts
Sources: Registration Rights Agreement (Quince Therapeutics, Inc.), Registration Rights Agreement (Sensei Biotherapeutics, Inc.)
Notifications. The Company will promptly notify the Investor promptly Purchasers of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding the Purchaser.
Appears in 2 contracts
Sources: Registration Rights Agreement (Rallybio Corp), Subscription Agreement (Rallybio Corp)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Equillium, Inc.), Registration Rights Agreement (Equillium, Inc.)
Notifications. The Company will promptly notify the Investor promptly Purchaser of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (Athira Pharma, Inc.), Registration Rights Agreement (Athira Pharma, Inc.)
Notifications. The Company will promptly notify the Investor promptly Buyer of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Equity Purchase Agreement (Skye Bioscience, Inc.), Equity Purchase Agreement (Skye Bioscience, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 2 contracts
Sources: Registration Rights Agreement (ImageneBio, Inc.), Registration Rights Agreement (ImageneBio, Inc.)
Notifications. The Company will promptly notify the Investor Buyer promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information..
Appears in 1 contract
Sources: Registration Rights Agreement (ProMIS Neurosciences Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Dogwood Therapeutics, Inc.)
Notifications. The Company will notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement, Warrant Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement, Warrant Initial Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Inhibikase Therapeutics, Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will notify the Investor Sellers promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Zevra Therapeutics, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information., in each case applicable to the Registrable Securities.
Appears in 1 contract
Sources: Registration Rights Agreement (Aspira Women's Health Inc.)
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf initial Registration Statement or any New new Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New new Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time Holders when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (ChargePoint Holdings, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any Registration Statement and any subsequent amendment to the Shelf Registration Statement or any New Registration Statementthereto, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Brickell Biotech, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents any document incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any written request by the SEC for any amendment or supplement to the Registration Statement (after the effectiveness of such Registration Statement), any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Processa Pharmaceuticals, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed filed, and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.. (b)
Appears in 1 contract
Sources: Registration Rights Agreement (AEON Biopharma, Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any Second Registration Statement, as applicable, or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement or any Second Registration Statement, as applicable, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Camp4 Therapeutics Corp)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC Commission and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC Commission for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Opus Genetics, Inc.)
Notifications. The Company will notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus relating to the Registrable Securities has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information, in each case applicable to the Registrable Securities.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any written request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Cue Biopharma, Inc.)
Notifications. The Company will notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional informationinformation regarding the Investors.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Summit Therapeutics Inc.)
Notifications. The Company will promptly notify the Investor Investors promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Initial Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Outset Medical, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf any Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the applicable Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement, any New Registration Statement or any New Special Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement, any Special Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will promptly notify the Investor promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract
Notifications. The Company will notify the Investor Holder promptly of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus or for additional information.
Appears in 1 contract
Sources: Registration Rights Agreement (Bitgo Holdings, Inc.)
Notifications. The Company will promptly notify the Investor promptly Investors of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional informationinformation regarding any Investor.
Appears in 1 contract
Sources: Registration Rights Agreement (Alaunos Therapeutics, Inc.)
Notifications. The Company will promptly notify the Investor promptly Warrantholder of the time when any subsequent amendment to the Shelf Initial Registration Statement or any New Registration Statement, other than documents incorporated by reference, has been filed with the SEC and/or has become effective or where a receipt has been issued therefor or any subsequent supplement to a Prospectus prospectus has been filed and of any request by the SEC for any amendment or supplement to the Registration Statement, any New Registration Statement or any Prospectus prospectus or for additional information.
Appears in 1 contract